GWEIX
Price
$37.61
Change
-$0.13 (-0.34%)
Updated
Jul 31 closing price
Net Assets
739.5M
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

GWEIX vs VSCIX

GWEIX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
GWEIX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GWEIX is a StrongBuy and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. GWEIX (740M). VSCIX pays higher dividends than GWEIX: VSCIX (1.23) vs GWEIX (0.17). GWEIX was incepted earlier than VSCIX: GWEIX (17 years) vs VSCIX (29 years). GWEIX (0.95) is less costly to investors than VSCIX (0.03). GWEIX is a more actively managed with annual turnover of: 33.00 vs. VSCIX (17.00). GWEIX has a lower initial minimum investment than VSCIX: GWEIX (100000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. GWEIX (15.86). VSCIX return over 5 years is better than : 35.13 vs. GWEIX (5.34).
GWEIXVSCIXGWEIX / VSCIX
Total Expense Ratio0.950.033,167%
Annual Report Gross Expense Ratio0.950.033,167%
Fund Existence17 years29 years-
Gain YTD13.42014.59192%
Front LoadN/AN/A-
Min. Initial Investment10000050000002%
Min. Initial Investment IRAN/AN/A-
Net Assets740M189B0%
Annual Yield % from dividends0.171.2313%
Returns for 1 year15.8622.5870%
Returns for 3 years24.9543.4457%
Returns for 5 years5.3435.1315%
Returns for 10 years58.69156.0738%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C